These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16619287)

  • 1. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity.
    Li D; Li H; Zhang P; Wu X; Wei H; Wang L; Wan M; Deng P; Zhang Y; Wang J; Liu Y; Yu Y; Wang L
    Eur J Immunol; 2006 May; 36(5):1324-36. PubMed ID: 16619287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S; Zhang H; Shi H; Yu X; Kong W; Li W
    Hum Immunol; 2008; 69(4-5):250-8. PubMed ID: 18486759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical safety evaluation of heat shock protein 65-MUC1 peptide fusion protein.
    Huo Y; Li B; Zhang Y; Wang S; Bao M; Gao X; Li D; Wang L; Yu Y; Wang J
    Regul Toxicol Pharmacol; 2007 Oct; 49(1):63-74. PubMed ID: 17600604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prokaryotic expression, purification of HSP65-MUC1 VNTR2 fusion protein and primary research on its tumoricidal effect].
    Zheng YL; Jiang H; Wang XL; Jiang YQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1014-6. PubMed ID: 17988580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yankai Z; Rong Y; Yi H; Wentao L; Rongyue C; Ming Y; Taiming L; Jingjing L; Jie W
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1365-71. PubMed ID: 16725110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
    Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
    Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
    Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
    Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of MUC1-specific cellular immunity by a recombinant BCG expressing human MUC1 and secreting IL2.
    He J; Shen D; O'Donnell MA; Chang HR
    Int J Oncol; 2002 Jun; 20(6):1305-11. PubMed ID: 12012014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
    Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a recombinant GnRH vaccine conjugated to heat shock protein 65 inhibits tumor growth in orthotopic prostate cancer mouse model.
    Xu J; Zhu Z; Wu J; Liu W; Shen X; Zhang Y; Hu Z; Zhu D; Roque RS; Liu J
    Cancer Lett; 2008 Feb; 259(2):240-50. PubMed ID: 18039558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice.
    Tanaka Y; Koido S; Chen D; Gendler SJ; Kufe D; Gong J
    Clin Immunol; 2001 Nov; 101(2):192-200. PubMed ID: 11683578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a non-tagged recombinant BCG heat shock protein 65-Her2 peptide fusion protein from Escherichia coli.
    Feng Y; Wan M; Xiang Z; Wei H; Hu X; Wang Y; Dai L; Fang M; Zhang X; Yu Y; Wang L
    Protein Expr Purif; 2007 Jun; 53(2):390-5. PubMed ID: 17275328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF.
    Yuan S; Shi C; Han W; Ling R; Li N; Wang T
    Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ
    J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
    Apostolopoulos V; Xing PX; McKenzie IF
    Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65.
    Zhang Y; Xu J; Zhao R; Liu J; Wu J
    Vaccine; 2007 Sep; 25(39-40):6911-21. PubMed ID: 17728021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccine.
    Chung MA; Luo Y; O'Donnell M; Rodriguez C; Heber W; Sharma S; Chang HR
    Cancer Res; 2003 Mar; 63(6):1280-7. PubMed ID: 12649188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response.
    Yang BF; Zhao HL; Xue C; Xiong XH; Zhang W; Yao XQ; Liu ZM
    Vaccine; 2007 May; 25(22):4478-86. PubMed ID: 17467856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
    Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T
    Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.